Synced daily from ClinicalTrials.gov via AACT. Last sync: .
15 Givinostat clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 9 indications (including Duchenne Muscular Dystrophy & Polycythemia Vera) and 1,086 total planned enrollment. 3 Phase 3 Givinostat trials and 5 Phase 2 are listed. 4 Givinostat clinical trials are actively recruiting at 15 U.S. sites across 13 states. Most recent activity: NCT06769633 (Dec 2029).
Where to Participate: All Givinostat Trial Sites in the U.S. (15 sites across 13 states)
Every actively recruiting Givinostattrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
15 Givinostat clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 4 are actively recruiting participants. 8 are marked completed.
Are Givinostat clinical trials recruiting in 2026?
Yes — 4 Givinostat trials are actively recruiting in 2026, with 15 U.S. sites across 13 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Givinostat being studied for?
Givinostat is being studied for Duchenne Muscular Dystrophy, Polycythemia Vera, Drug Drug Interaction, Becker Muscular Dystrophy, Heathy Volunteer and 5 more. The trials are grouped by indication on this page.
What phase is Givinostat in?
Givinostat clinical trials span 3 Phase 3, 5 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Givinostat clinical trials?
The lead sponsor across the most Givinostat trials is Italfarmaco. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Givinostatas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.